U.S. Consumer Finance Stock News

Chevron (NYSE:CVX) is under growing scrutiny in California over its gasoline pricing and record retail margins at the pump. A new report links Chevron to a funded advocacy group that is actively lobbying to shape public views on high fuel prices. State officials and consumer groups are questioning whether Chevron is using market power to influence margins and blame public policy for price volatility. The tension coincides with geopolitical supply shocks and major operational updates across...

Quanta’s earnings beat and guidance raise Quanta Services (PWR) has drawn fresh attention after reporting first quarter 2026 results that exceeded market revenue expectations and lifting full year revenue and earnings guidance on the back of a record project backlog. See our latest analysis for Quanta Services. The earnings beat and guidance hike have come alongside strong price momentum, with a 37.6% 1 month share price return, a 75.5% year to date share price return and a very large 5 year...

In recent weeks, Lockheed Martin reported softer first-quarter 2026 earnings and reaffirmed its full-year 2026 guidance while also filing a debt shelf registration and securing new defense work, including a U.S. Space Force Space-Based Interceptor development award and Peru’s order for 12 F‑16 Block 70 aircraft. At the same time, Lockheed Martin’s Skunk Works MDCX platform successfully controlled the U.S. Navy’s first MQ‑25A Stingray flight and the company advanced a new modular 5G defense...

Aviat Networks (AVNW) has just put out its Q3 2026 scorecard, reporting Q2 fiscal 2026 revenue of US$111.5 million and basic EPS of US$0.44 on net income of US$5.7 million. Over the last few quarters, revenue has ranged from US$88.4 million to US$118.2 million, while quarterly basic EPS has swung from a loss of US$0.94 to a profit of US$0.44. On a trailing twelve month basis, EPS is US$1.15 on net income of US$14.6 million from US$446.8 million in revenue. For investors, this mix of higher...

Backblaze Q1 2026 earnings snapshot Backblaze (BLZE) has just updated investors with Q1 2026 results against a backdrop where trailing 12 month revenue sits at about US$145.8 million and the company remains loss making, with basic EPS of US$0.46 loss on this basis as of Q4 2025. Over recent quarters, the company has seen quarterly revenue move from US$33.8 million in Q4 2024 to US$37.8 million in Q4 2025. Basic EPS shifted from a loss of US$0.30 per share to a loss of US$0.09 per share across...

Delta Air Lines is experiencing major operational disruptions with hundreds of flight cancellations, leading to widespread passenger frustration. Alongside these disruptions, Delta is committing $500 million to a 4% wage increase for its global workforce, its fifth consecutive annual pay raise. The combination of service issues and employee focused investment is drawing attention to the company’s operational resilience, labor relations and brand perception. For investors watching NYSE:DAL,...

Parker-Hannifin (NYSE:PH) has announced an 11% increase in its quarterly dividend. This marks the company’s 304th consecutive quarterly dividend payment. The new dividend continues Parker-Hannifin’s long history of returning cash to shareholders. Parker-Hannifin, trading at $872.69, has seen its stock return 43.5% over the past year and 197.0% over the past 5 years. Those numbers, alongside a value score of 1, frame this 11% dividend hike as part of a broader story of shareholder-focused...

Jack Welch Management Institute at Strayer University was ranked #8 among U.S. online MBA programs by CEO Magazine. The program was also ranked #30 among global online MBA programs. This is the 10th consecutive year the institute has been included in the U.S. top 10. For investors watching Strategic Education (NasdaqGS:STRA), this recognition highlights an important asset within the group. JWMI sits inside Strayer University, giving the company a branded MBA offering in a crowded online...

TransDigm Group (TDG) has just posted another set of detailed numbers, with Q1 2026 revenue at US$2.3b and basic EPS of US$6.63, supported by trailing twelve month revenue of US$9.1b and EPS of US$31.08. Over recent quarters the company has seen revenue move from US$2.2b in Q4 2024 to between roughly US$2.0b and US$2.4b through 2025, while quarterly EPS ranged from US$5.79 to US$8.47, setting up a picture of robust scale and consistent profit generation as margins hold close to 20%. See our...

If you are wondering whether CRISPR Therapeutics at around US$52 per share looks like an opportunity or a stock to be cautious on, the key is understanding what that price actually builds in. The stock has delivered a 58.0% return over the last year, even though the year to date return is slightly negative at 2.6%, with shorter term moves of 0.6% over 7 days and 5.8% over 30 days adding extra noise on top. Recent headlines around CRISPR Therapeutics have focused on its gene editing platform...

Valaris (VAL) sets the stage with profit-heavy recent results Valaris (VAL) heads into its Q1 2026 update off a very earnings rich 2025 finish, with Q4 revenue of US$537.4 million and basic EPS of US$10.32, underpinned by trailing twelve month net income of US$982.8 million and EPS of US$13.92. Over the past year the company has seen revenue hold around the US$2.4 billion mark on a trailing basis while quarterly revenue moved from US$620.7 million in Q1 2025 to US$537.4 million in Q4 2025,...

In April 2026, Clarivate Plc reported first-quarter 2026 results showing sales of US$585.5 million versus US$593.7 million a year earlier, a smaller net loss of US$40.2 million, reaffirmed full-year 2026 guidance, and continued its share buyback while also introducing Nexus Connect, an AI gateway linking university resources to chat agents like ChatGPT and Claude. The launch of Nexus Connect highlights Clarivate’s effort to embed its academic content and services directly into widely used AI...

Paymentus Holdings (PAY) has just reported its Q1 2026 results against a backdrop where Q4 2025 revenue was US$330.5 million and basic EPS came in at US$0.16, while trailing twelve month EPS reached US$0.53 on revenue of about US$1.2 billion and earnings growth was cited at 51.5% year over year. Over the past six quarters, the company has seen quarterly revenue move from US$231.6 million in Q3 2024 to US$330.5 million in Q4 2025, with basic EPS ranging from US$0.11 to US$0.16. Trailing...

If you are wondering whether Grand Canyon Education at around US$169 per share looks attractively priced or stretched, it starts with understanding how its current market value lines up with the fundamentals. The stock has had a mixed run, with a 0.8% return over the last week, a 1.2% decline over the last month, a 2.3% gain year to date, and an 8.7% decline over the last year, while the 3 year and 5 year returns sit at 52.7% and 81.8% respectively. Recent news flow around Grand Canyon...

Huntington Ingalls Industries (HII) has opened Q1 2026 earnings season with a backdrop of solid recent numbers, capped by Q4 2025 revenue of US$3.5 billion, basic EPS of US$4.05, and quarterly net income of US$159 million. These figures together feed into trailing twelve month EPS of US$15.39 on US$12.5 billion of revenue. Over the past few quarters, the company has reported revenue of US$2.7 billion in Q1 2025, US$3.0 billion in Q4 2024, and US$3.5 billion in Q4 2025, while quarterly basic...

If you are wondering whether DXC Technology's current share price lines up with its underlying value, this article will walk through the key signals to help you frame that question clearly. At a last close of US$11.86, the stock shows a mixed recent return profile, with a 2.9% gain over the past week but declines of 6.3% over 30 days, 15.8% year to date and 23.5% over the last year, extending to 47.7% over three years and 65.1% over five years. These price moves sit against a backdrop of...

Cryoport’s Q1 2026 Earnings in Focus Cryoport (CYRX) has just reported its Q1 2026 results with recent quarterly revenue most recently at about US$45.5 million and a basic EPS loss of US$0.21, keeping the spotlight firmly on how efficiently the company is converting top line into earnings. The company has seen revenue move from US$41.5 million in Q4 2024 to US$45.5 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.39 to a loss of US$0.17 over that period. This gives...

Investors may be wondering if TD SYNNEX at around US$234.72 still offers value after its strong run, or if most of the upside has already been priced in. The stock has recently delivered returns of 5.1% over 7 days, 25.6% over 30 days, 53.0% year to date and 107.9% over 1 year, which can change how investors think about both opportunity and risk. Recent coverage has focused on TD SYNNEX in the context of broader technology and IT distribution themes, with attention on how its scale and role...

Wondering if Rivian Automotive at US$14.60 is an opportunity or a value trap? This article breaks down what the current price really implies. The stock has been volatile, with returns of a 9.5% decline over 7 days, a 5.2% decline over 30 days and a 24.8% decline year to date. It also shows an 8.1% return over 1 year and 5.3% over 3 years. Recent headlines around Rivian continue to focus on its position in the electric vehicle space and how the market views its long term potential. This can...

Energy Transfer (ET) opened the 2026 earnings season with Q1 numbers that sit against a backdrop of steady top line and consistent profitability over the last year, with trailing twelve month revenue at about US$85.5b and basic EPS of US$1.22. The company has seen quarterly revenue range from US$19.2b to US$25.3b across 2025, while basic EPS moved from US$0.37 in Q1 2025 to US$0.25 in Q4 2025, setting the stage for investors to focus on how much of that earnings power can be maintained...

Researchers are studying semaglutide, used in Novo Nordisk’s GLP 1 therapies, for its potential to reduce heavy drinking in patients with alcohol use disorder. Novo Nordisk and Lexicon Pharmaceuticals have started a Phase 1 trial of LX9851, a new obesity and metabolic disorder drug candidate. These developments suggest possible expansion of Novo Nordisk’s treatment areas beyond diabetes and obesity. For investors tracking NYSE:NVO, these clinical moves arrive as the stock trades at $44.87,...

Surgery Partners (SGRY) has just wrapped up Q1 2026, with its latest reported quarter, Q4 2025, showing revenue of US$885 million and a basic EPS loss of US$0.12, alongside net income excluding extra items of a US$15 million loss. Looking back over 2025, the company reported revenue increasing from US$776 million in Q1 to US$885 million in Q4, while quarterly basic EPS losses ranged from US$0.30 in Q1 to US$0.02 in Q2 and US$0.18 in Q3. This presents a picture in which the top line is...

Rhythm Pharmaceuticals (RYTM) has just reported Q1 2026 results, with trailing twelve month revenue of about US$189.8 million and a net loss of roughly US$201.9 million, which translates into basic EPS of US$3.11 in losses. Over recent quarters, revenue has moved from US$41.8 million in Q4 2024 to US$57.3 million in Q4 2025, while quarterly basic EPS losses have ranged between about US$0.73 and US$0.82 per share. For investors, the focus is now on whether that expanding top line can...

JELD-WEN Holding (JELD) has reported its latest results with Q4 2025 revenue of US$802 million and a basic EPS loss of US$0.49, while trailing twelve month figures show revenue of about US$3.2 billion and a basic EPS loss of US$7.30. Over recent quarters, the company has seen revenue move from US$895.7 million in Q4 2024 to US$776.0 million in Q1 2025 and then into the US$800 million range in Q2 to Q4 2025. This has come alongside basic EPS losses between roughly US$0.26 and US$4.30 per...